Preventive effects of 1,25-(OH)2 VD3 against ConA-induced mouse hepatitis through promoting vitamin D receptor gene expression

Acta Pharmacologica Sinica

Volumn 31, Issue 6, 2010, Pages 703-708

  Hu, Xu Dong ^a   Jiang, Shi Li ^a   Liu, Cheng Hai ^a   Hu, Yi Yang ^a   Leu, Cheng ^a   Sun, Ming Yu ^a   Chen, Gao Feng ^a   Liu, Ping ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

1,25 dihydroxyvitamin D3; Concanavalin A; Hepatitis; Interferon ; Interleukin 4; Interleukin 5; Vitamin D receptor

Indexed keywords

ALANINE AMINOTRANSFERASE; CALCITRIOL; CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; VITAMIN D RECEPTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GENE EXPRESSION; HEPATITIS; HISTOPATHOLOGY; LIVER PROTECTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ALANINE TRANSAMINASE; ANIMALS; CALCITRIOL; CD4-CD8 RATIO; CONCANAVALIN A; CYTOKINES; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; FEMALE; GENE EXPRESSION; HEPATITIS, AUTOIMMUNE; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED BALB C; RECEPTORS, CALCITRIOL; RNA, MESSENGER; SPLEEN; VITAMINS;

EID: 77953271178     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.53     Document Type: Article

References (31)

1. Meyer zum Büschenfelde KH, Dienes HP. Autoimmune hepatitis. Definition-classification-histopathology-immunopathogenesis. Virchows Arch 1996; 429: 1-12.
2. Czaja AJ. Autoimmune hepatitis-approach to diagnosis. Med Gen Med 2006; 8: 55.
3. Maggs J, Cullen S. Management of autoimmune liver disease. Minerva Gaastroenterol Dietol 2009; 55: 173-206.
4. Béland K, Lapierre P, Alvarez F. Influence of genes, sex, age and environment on the onset of autoimmune hepatitis. World J Gastroenterol 2009; 15: 1025-1034
5. Ahn J, Flamm SL. Autoimmune hepatitis. Curr Treat Options Gastroenterol 2005; 8: 481-492
6. Fisher L, Fisher A. Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease. Clin Gastroenterol Hepatol 2007; 5: 513-520
7. Saron ML, Godoy HT, Hessel G. Nutritional status of patients with biliary atresia and autoimmune hepatitis related to serum levels of vitamins A, D, and E. Arq Gastroenterol 2009; 46: 62-68
8. Van Hoof HJ, Sninkele LM, Ross HA, Sweep CG, Benraad TJ. Determination of on-protein-bound plasma 1,25-dihydroxyvitamin D by symmetric (rate) dialysis. Anal Biochem 1998; 258: 176-183
9. Deluca HF, Cantorna MT. Vitamin D: its role and uses in immunology. FASEB J 2001; 15: 2579-2585
10. Lemire JM. Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 1995; 53: 599-602.
11. Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: Preferential inhibition of Th1 functions. J Nutr 1995; 125: 1704S-8S.
12. Teodora P, Staeva V, Leonard PF. 1,25-Dihydroxyvitamin D3 inhibits IFN-?α and IL-4 levels during in vitro polarization of primary murine CD4 T cells. J Immunol 2002; 168: 1181-1189
13. D'Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998; 101: 252-262
14. Luciano A. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol 2002; 2: 1017-1028
15. Zhang AB, Zheng SS, Jia CK, Wang Y. Effect of 1,25-dihydroxyvitamin D3 on preventing allograft from acute rejection following rat orthotopic liver transplantation. World J Gastroenterol 2003; 9: 1067-1071
16. Nashold FE, Miller DJ, Hayes CE. 1,25-dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 2000; 103: 171-179
17. Zella JB, DeLuca HF. Vitamin D and autoimmune diabetes. J Cell Biochem 2003; 88: 216-222
18. Cantorna MT, Hayes CE, DeLuca HF. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998; 128: 68-72.
19. Lemire JM, Ince A, Takashima M. 1,25-dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MRL/1 mice. Autoimmunity 1992; 12: 143-148
20. Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr 2000; 130: 2648-2652
21. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992; 90: 196-203.
22. Scott MJ, Godshall CJ, Cheadle WG. Jaks, STATs, Cytokines, and Sepsis. Clin Diagn Lab Immunol 2002; 9: 1153-1159
23. Coffman RL, Weid T von der, Coffman RL, T von der Weid. Multiple pathways for the initiation of T helper 2 (Th2) responses. J Exp Med 1997; 185: 373-375
24. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A induced T-cell-mediated hepatic injury in mice: The role of tumor necrosis factor. Hepatology 1995; 21: 190-198
25. Tsuchiya T, Ohshima K, Karube K, Yamaguchi T, Suefuji H, Hamasaki M, et al. Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL. Blood 2004; 103: 236-241
26. Kremer M, Hines IN, Milton RJ, Wheeler MD. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis. Hepatology 2006; 44:216-227
27. Trautwein C, Rakemann T, Brenner DA, Streetz K, Licato L, Manns MP, et al. Concanavalin A induced liver cell damage: activation of intracellular pathways triggered by tumor necrosis factor in mice. Gastroenterology 1998; 114: 1035-1045
28. Mizuhara H, Uno M, Seki Y, Yamashita M, Yamaoka M, Ogawa T, et al. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of' interleukin-6 for the manifestations of hepatitis H1. Hepatology 1996; 23: 1608-1615
29. Dimitrova P, Skapenko A, Herrmann ML, Schleyerbach R, Kalden JR, Schulze-Koops H. Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation. J Immunol 2002; 169: 3392-3399
30. Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology 2006; 147: 5542-5548
31. Cippitelli M,Santoni A. Vitamin D3: a transcriptional modulator of the interferon-gamma gene. Eur J Immunol 1998; 28: 3017-3030